Physician profile
Jayprakash Patel
NPI 1124086541
$18,769.47
in general payments reported to CMS, 2019-2025
47 companies · $2,336 in 2025
The $2,336 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,111 · 2020: $61.07 · 2021: $1,754 · 2022: $2,520 · 2023: $1,817 · 2024: $9,171 · 2025: $2,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,315 · Consulting Fee: $5,000 · Travel and Lodging: $3,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,314.77 |
| Consulting Fee | $5,000.00 |
| Travel and Lodging | $3,008.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $7,156.38 | 2024 | |
| Procept Biorobotics Corporation | $1,685.87 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $1,677.96 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Lithovue |
| Teleflex LLC | $1,371.58 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $792.30 | 2021-2025 | Prolaris |
| Astellas Pharma US INC | $713.23 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $638.89 | 2019-2025 | |
| Antares Pharma, INC. | $628.21 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $615.63 | 2021-2024 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $304.54 | 2019-2025 | Adstiladrin, Rebyota |
| Aytu Biopharma, INC. | $247.03 | 2019 | |
| Janssen Biotech, INC. | $220.03 | 2019-2024 | Erleada |
| Merck Sharp & Dohme LLC | $214.51 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Myovant Sciences INC. | $170.89 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $169.89 | 2019-2025 | Bard Urinary Drainage Bag |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abc Home Medical Supply, INC. | $157.29 | 2025 | |
| Calyxo, INC. | $156.53 | 2025 | Cvac Aspiration System |
| Neotract INC. | $155.87 | 2019 | |
| Allergan, INC. | $148.75 | 2019-2021 | |
| Pfizer INC. | $137.10 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $128.87 | 2023-2024 | Orgovyx, Gemtesa |
| Srs Medical Systems, INC. | $119.86 | 2022-2023 | Urocuff |
| Urogen Pharma, INC. | $117.52 | 2021-2025 | Jelmyto |
| Endo USA, INC. | $99.11 | 2024-2025 | Xiaflex |
| Becton, Dickinson and Company | $92.92 | 2024 | Bard Urinary Drainage Bag |
| Blue Earth Diagnostics | $90.97 | 2021-2022 | |
| Urovant Sciences INC | $88.13 | 2021-2022 | |
| Tolmar, INC. | $84.92 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $78.18 | 2022-2023 | Pylarify |
| Rochester Medical Corporation | $75.84 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.67 | 2022-2023 | |
| Convatec INC. | $47.30 | 2021-2024 | |
| Agiliti Health, INC. | $46.14 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
| Tolmar Pharmaceuticals, INC. | $36.39 | 2022 | |
| Ambu INC. | $32.48 | 2021 | |
| Menarini Silicon Biosystems, INC. | $27.68 | 2023 | Cellsearch |
| Dendreon Pharmaceuticals LLC | $22.93 | 2021 | |
| Axonics, INC. | $22.38 | 2024 | Axonics |
| Halozyme INC | $20.84 | 2023 | |
| Ge Healthcare | $17.88 | 2019 | |
| Lumenis, INC | $16.36 | 2021 | |
| Ets Wound Care LLC | $15.12 | 2023 | |
| Clarus Therapeutics INC. | $14.40 | 2021 | |
| Laborie Medical Technologies Corp. | $13.68 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Hollister Incorporated | $13.50 | 2021 | |
| Genzyme Corporation | $12.24 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayprakash Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.